Harnessing Ocular Physiology: Fast and Sustained Tear Production With TRYPTYR® (acoltremon ophthalmic solution) 0.003% for Dry Eye Disease
Data from the pivotal COMET clinical trials reveal how the first topical ocular neuromodulator approved for the signs and symptoms of DED, TRYPTYR®, delivers a rapid increase in natural tear production.
John Hovanesian, MD (Moderator)*; Marjan Farid, MD*; Nate Lighthizer, OD*; Selina McGee, OD*
Cataract and Refractive Surgery Today 